In addition, some authors have attempted to correlate TMZ resistance in GBM patients to the presence of P-glycoprotein (P-gp) acts as an efflux pump that expels the drug from the cell, thus reducing its effectiveness, in the membrane of tumor cells [10,17]. The gene discussed is ABCB1; the disease is neoplasm.